Clinical Trials with Pegylated Liposomal Doxorubicin in the Treatment of Ovarian Cancer

Among the pharmaceutical options available for treatment of ovarian cancer, increasing attention has been progressively focused on pegylated liposomal doxorubicin (PLD), whose unique formulation prolongs the persistence of the drug in the circulation and potentiates intratumor accumulation. Pegylate...

Descripción completa

Detalles Bibliográficos
Autores principales: Pisano, Carmela, Cecere, Sabrina Chiara, Di Napoli, Marilena, Cavaliere, Carla, Tambaro, Rosa, Facchini, Gaetano, Scaffa, Cono, Losito, Simona, Pizzolorusso, Antonio, Pignata, Sandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612436/
https://www.ncbi.nlm.nih.gov/pubmed/23577259
http://dx.doi.org/10.1155/2013/898146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612436/
https://www.ncbi.nlm.nih.gov/pubmed/23577259
http://dx.doi.org/10.1155/2013/898146

Ejemplares similares